Therefore, WHO expanded their AlereLAM recommendations in 2019,9, 10, 11 such that for all hospitalised people with HIV who present with signs or symptoms of tuberculosis, signs of serious illness, or CD4 counts of less than 200 cells per μL, and outpatients with HIV who present with signs or symptoms of tuberculosis, signs of serious illness, or CD4 counts of less than 100 cells per μL are recommended to undergo an AlereLAM test. The gene discussed is CD4; the disease is tuberculosis.